Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Frankie Ann Holmes, MD
Published: Friday, Sep 01, 2017



Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.

There will always be patients who do not choose to receive chemotherapy for tumors that are too large to remove by surgery, states Holmes. Some fast-growing tumors in select breast cancer subtypes may respond to deprivation of estrogen more than chemotherapy, explains Holmes.



Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.

There will always be patients who do not choose to receive chemotherapy for tumors that are too large to remove by surgery, states Holmes. Some fast-growing tumors in select breast cancer subtypes may respond to deprivation of estrogen more than chemotherapy, explains Holmes.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Publication Bottom Border
Border Publication
x